CBD 101:
Is CBD Legal in South Dakota? South Dakota Cannabis, Hemp, and CBD Laws (2026)
Compliant hemp-derived CBD is available in South Dakota, subject to total-THC, manufacturing and product-use restrictions. CBD made from marijuana is treated as a controlled substance and is available only to patients enrolled in the state’s medical cannabis program. That basic split — hemp-derived CBD for the general public, marijuana-derived CBD for registered patients — has held since 2020, but the rules around hemp have tightened sharply since then, and a law signed in 2026 schedules the end of the state hemp licensing program for January 1, 2027.
This guide explains what is legal to buy, sell, and carry in South Dakota today, who can buy it, and how the state’s hemp and cannabis laws fit together. South Dakota is one of the states that allow CBD only under specific conditions, so the details are worth getting right before you shop.
Is CBD legal in South Dakota?
Hemp-derived CBD is legal in South Dakota; marijuana-derived CBD is not, unless you are a medical cannabis patient. The state’s hemp definition uses no more than 0.3% total delta-9 THC, including the potential contribution from THCA. A low delta-9-only result is insufficient. Finished CBD products must also meet other requirements; the hemp definition does not authorize every gummy, drink or pet product.
Two limits matter even for legal hemp CBD. First, the cannabinoids have to be naturally derived rather than chemically converted in a lab. Second, South Dakota prohibits hemp products intended for smoking or inhaling, so hemp flower and hemp vapes are off-limits even when the CBD itself is legal. Non-inhalable formulations must still comply with food, drug, cosmetic and other applicable rules.
How South Dakota legalized hemp and CBD
South Dakota legalized hemp and hemp-derived CBD in 2020 through House Bill 1008. Then-Governor Kristi Noem signed the bill into law on March 27, 2020, after vetoing an earlier hemp measure the year before. The law legalized the cultivation, processing, and sale of industrial hemp and its derivatives, provided they stay at or below 0.3% delta-9 THC, and placed those rules in Chapter 38-35 of the South Dakota Codified Laws.
For everyday consumers, the practical effect is simple: consumers do not need a medical cannabis card merely to purchase a compliant hemp CBD product. The growing and processing side was the regulated part. The South Dakota Department of Agriculture & Natural Resources (DANR) administers the state’s hemp program during the transition, licensing growers and processors, running background checks, and inspecting and testing crops to confirm they met the THC limit. The same 2020 law carried the ban on smoking or inhaling hemp that still applies today.
State Hemp Oversight Changes on January 1, 2027
Senate Bill 39 was signed March 17, 2026, with an effective date of January 1, 2027. It repeals substantial parts of the state hemp licensing framework and recognizes producers licensed by USDA or a tribal program. The transition should not be described as already complete during 2026.
The enacted text retains transport documentation requirements and requires a licensed producer to cultivate hemp. It is therefore not a move to unlicensed cultivation. Growers should confirm their authorization for the relevant growing season rather than assume a current state permit automatically covers later operations.
The change also does not repeal the separate restrictions on chemically derived cannabinoids or selling or using hemp for smoking or inhaling. It changes production oversight, not every consumer-product rule.
Delta-8 and other lab-converted cannabinoids are banned
Chemically derived delta-8 and other covered cannabinoids cannot lawfully be sold as hemp in South Dakota. The state banned them through House Bill 1125, which took effect on July 1, 2024. Section 34-20B-118 prohibits specified chemical conversions and the sale or distribution of hemp products containing chemically derived cannabinoids, and it names the cannabinoids it targets — delta-8 THC, delta-10 THC, THC-O acetate (THC-O), HHC, and THC-P — when they are produced by chemical conversion. Violating the ban is a criminal offense.
The distinction the law draws is between naturally occurring and “chemically derived” cannabinoids. Delta-8 and delta-10 exist in hemp only in trace amounts, so marketable products are usually made by chemically converting CBD into those compounds — exactly the process House Bill 1125 outlaws. Natural extraction avoids the chemical-conversion issue, but does not settle every other requirement. Total THC, intended use, food and drug rules and the federal transition can still exclude a product. A naturally extracted cannabinoid is not an automatic retail exemption.
This was a sharp turn. As recently as 2022, South Dakota had chosen to regulate delta-8 by age rather than ban it. State and local authorities began actively enforcing the 2024 ban in 2025, pulling non-compliant products from store shelves, so retailers need reliable product records. A potency certificate identifies tested cannabinoids; by itself, it does not prove the manufacturing process or establish complete legal compliance.
Marijuana-derived CBD and the medical cannabis program
CBD made from marijuana is legal in South Dakota only for registered medical cannabis patients. Voters created that pathway in November 2020 by approving Initiated Measure 26 with about 70% support, and the program is run by the South Dakota Department of Health.
Under the medical cannabis program, a patient first gets a written certification from a healthcare practitioner — a physician, physician assistant, or advanced practice registered nurse licensed in South Dakota and registered with the program — then applies to the Department of Health for a registry card. The practitioner must certify a debilitating medical condition within the program’s eligibility requirements; the process is not unrestricted approval for any illness. Registered patients can buy and possess medical cannabis — including marijuana-derived CBD and higher-THC products — from licensed dispensaries, subject to the program’s three-ounce limit and product-equivalency rules. Authorized home cultivation has additional provisions. The program tracks products from seed to sale through licensed cultivators, manufacturers, testing facilities, and dispensaries.
Adults 18 and older can hold a card in their own name; minors can qualify, but a parent or guardian must consent and act as their caregiver. This is a meaningful change from South Dakota’s older, narrower approach to medical CBD, and it sits alongside the rest of South Dakota’s cannabis laws.
Is recreational marijuana legal in South Dakota?
No. Recreational marijuana is not legal in South Dakota, which remains a medical-only state. The path there has been unusually rocky. In 2020, voters approved Constitutional Amendment A to legalize adult-use cannabis by a margin of about 54% to 46%, but the South Dakota Supreme Court struck it down for violating the state constitution’s single-subject rule for ballot measures.
Voters have since rejected legalization twice more. Initiated Measure 27 failed in 2022, and Initiated Measure 29 failed on November 5, 2024, with about 55.5% voting no. Until that changes, possessing or selling marijuana outside the medical program carries criminal penalties.
Who Can Buy CBD in South Dakota?
A retailer’s age policy is different from a statutory restriction. Do not apply one generalized 18-or-21 rule to every hemp product.
The current under-21 statute, amended in 2026, specifically covers consumable products containing delta-8 THC, delta-9 THCA, THC-O acetate or HHC. It restricts sales and distribution to people under 21 and their purchase, receipt, possession and consumption, with specified practitioner-order exceptions. The age provision does not legalize products otherwise prohibited by the conversion ban.
Compliant hemp CBD is distinct from medical cannabis, which requires the relevant patient authorization and adherence to its possession rules. Neither a laboratory report nor a seller’s age-verification screen substitutes for those requirements.
Federal Food Rules and the 2026 Hemp Transition
The 2018 Farm Bill removed qualifying hemp from federal marijuana controls but preserved the FDA’s authority over finished products. CBD cannot lawfully be marketed as a dietary supplement or added to food introduced into interstate commerce. A hemp-derived source does not cure those restrictions.
Epidiolex is an approved prescription CBD medicine for specified seizure disorders. Ordinary retail CBD products have not been approved as equivalent treatments, and unsupported disease-treatment claims can make them unlawfully marketed drugs.
Public Law 119-37 narrows the federal hemp definition. It includes a finished-product threshold of 0.4 mg per container of combined THC, THCA and specified similar-effect cannabinoids, alongside manufacturing exclusions. That is not a CBD-dose cap or a per-serving allowance.
Section 2019 of the September extension delays most changes to December 11, 2026. Exclusions for cannabinoids the plant cannot naturally produce remain scheduled for November 12. Most other provisions, including the container threshold and the exclusion for naturally occurring cannabinoids manufactured outside the plant, follow in December.
Full-spectrum CBD may exceed the future container limit despite meeting a percentage threshold. THC-free CBD also requires evaluation against the manufacturing and finished-product rules rather than an assurance that all isolate products are unaffected. Our coverage of the federal delay debate provides context. The federal deadlines are separate from South Dakota’s January 2027 production-oversight transition.
Where to buy CBD in South Dakota
Compliant CBD is sold across South Dakota in CBD and vape shops, wellness centers, pharmacies, and grocery stores, as well as online with delivery to the state. Because the state bans hemp products meant to be smoked or inhaled, consumers should distinguish permitted non-inhalable products from unlawful inhalable hemp and from CBD foods subject to separate restrictions. Whether you buy in person or online, compare the package with a batch-specific cannabinoid and contaminant report, including THCA. Ask for sourcing and manufacturing documentation where relevant; a potency report alone does not prove natural extraction or legal compliance.












